Role of n6-methyladenosine methylation regulators in the drug therapy of digestive system tumours

HIGHLIGHTS

  • who: Xia Z and collaborators from the Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China, Zhongnan Hospital of have published the Article: Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours, in the Journal: (JOURNAL)
  • how: These results indicated that m6A modification promotes HCC resistance to SOR through the circRNA expression level.
  • future: An m6A regulator based on natural product discovery is considered the future research direction. Studies on the mechanism of METTL14 resistance are required.

SUMMARY

    Liver cancer is the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?